Magnetic resonance techniques for the identification of patients with symptomatic carotid artery occlusion at high risk of cerebral ischemic events

Stroke

Volumn 31, Issue 12, 2000, Pages 3001-3007

  Klijn, Catharina J M ^a   Kappelle, L Jaap ^a   Van Der Grond, Jeroen ^a   Algra, Ale ^a   Tulleken, Cornelis A F ^a   Van Gijn, Jan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carotid artery occlusion; Outcome; Spectroscopy, nuclear magnetic resonance

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYMPTOM;

EID: 0033662012     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.12.3001     Document Type: Article

References (44)

1. EC-IC bypass 10 years later: Is it valuable?
2. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial
3. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases
4. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion
5. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease
6. Influence of cerebral hemodynamics on stroke risk: One-year follow-up of 30 medically treated patients
7. Sequential change of hemodynamic reserve in patients with major cerebral artery occlusion or severe stenosis
8. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity
9. Course of cerebrovascular reactivity in patients with carotid artery occlusions
10. Course of carotid artery occlusions with impaired cerebrovascular reactivity
11. Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk
12. Multifunctional magnetic resonance imaging of cerebrovascular disease
13. Imaging of acute cerebral ischemia
14. Role of collateral flow on cerebral hemodynamics in patients with a unilateral ICA occlusion
15. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction
16. Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke
17. 1H-MR spectroscopic imaging study
18. Cerebral metabolism of patients with stenosis of the internal carotid artery before and after endarterectomy
19. Symptomatic carotid artery occlusion: A reappraisal of hemodynamic factors
20. Interobserver agreement for the assessment of handicap in stroke patients
21. How to measure carotid stenosis
22. High-flow Excimer laser-assisted extra-intracranial and intra-intracranial bypass
23. The modified Excimer laser-assisted high-flow bypass operation
24. Assessment of borderzone ischemia with a combined MR imaging-MR angiography-MR spectroscopy protocol
25. A computed tomographic guide to the identification of cerebral vascular territories
26. Clinical and hemodynamic aspects of low flow infarcts
27. Carbon dioxide reactivity and patterns of cerebral infarction in patients with carotid artery occlusion
28. A transcranial Doppler study of vasomotor reactivity in symptomatic carotid occlusion
29. 2 reactivity in the diagnosis of cerebral low flow infarcts
30. Borderzone infarctions distal to internal carotid artery occlusion: Prognostic implications
31. A quantitative investigation of the variability of the major cerebral arterial territories
32. Failure to identify cerebral infarct mechanisms from topography of vascular territory lesions
33. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
34. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy
35. 1H-NMR spectroscopic studies of brain
36. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
37. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
38. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction
39. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: Relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome
40. 1H magnetic resonance spectroscopy study
41. Acute stroke: Evaluation with serial proton MR spectroscopic imaging
42. Proton magnetic resonance spectroscopy of human brain: Application to normal white matter, chronic infarction, and MRI white matter signal hyperintensities
43. Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes
44. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction